AEHR Stock Price Today (October 2026) — Aehr Test Systems, Inc. Analysis & Key Metrics 2026-10-08
Aehr Test Systems, Inc. (AEHR) is trading at $87.21, down 2.42% today (as of October 2026). The stock continues to show pressure below major moving averages, attracting attention from investors looking for Technology growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $128.00 (46.8% upside).
- Volatility is high (66.60% annualized), implying wide price swings for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: solid revenue growth (33.70% YoY) alongside competitive pressures in the Semiconductor Equipment & Materials space.
AEHR Stock Analysis: Key Metrics & Valuation (October 2026)
Concise, actionable data for investors
Aehr Test Systems, Inc. - Historical Price & Volume
- Price
- Volume
- Latest price
Market Cap
Enterprise Value: $2.74B
P/E Ratio
Forward P/E: 57.30
Revenue Growth
Year over Year
Analyst Target
+46.8% upside potential
Key Investor Questions About AEHR
What investors need to know before buying
Based on current market data, AEHR presents a neutral technical setup with looking solid fundamentals.
- Technicals say: Neutral (RSI 37.90)
- Fundamentals say: Looking solid (debt and growth supportive)
AEHR's growth trajectory depends on its ability to expand within the Semiconductor Equipment & Materials sector while managing margin pressures.
- Future growth will depend on performance in core Semiconductor Equipment & Materials operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for AEHR investors include debt exposure and competitive dynamics in the Semiconductor Equipment & Materials industry.
- $9.88M in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Semiconductor Equipment & Materials.
52-Week Trading Range
Over the past year, AEHR stock traded between $18.70 and $147.40 and currently trades in the middle of that range. Big swings are likely unless a major catalyst emerges.
Volatility & Risk Profile
With 66.60% annualized volatility and β=4.93, the stock exhibits high sensitivity to market moves—making AEHR suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
High institutional backing, but elevated short interest signals a potential battleground stock.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines and coverage
AEHR at 18.59X Sales: Market Loves Its AI Story, But is Love Blind?
Aehr Test Systems' 363% 2026 surge and 18.59X sales multiple reflect AI optimism, but customer concentration and execution risks leave little room for error.
Better Artificial Intelligence Stock: Aehr Test Systems vs. KLA Corporation
One niche player burned cash and posted a net loss; the other generated $3.8 billion in free cash flow.
Better Artificial Intelligence Stock: Aehr Test Systems vs. Super Micro Computer
Aehr trades at a steep premium despite recent losses, while Super Micro's valuation looks cheap relative to its growth, but both carry hidden risks.
Can AEHR's Diversification Strengthen Its Growth Outlook?
Aehr broadens beyond SiC as AI, silicon photonics and power semiconductors fuel a more diversified growth story.
Aehr Poised for AI-Driven Inflection as Rising Chip Value Raises Cost of Late Failures, Oppenheimer Says
Aehr Test Systems (AEHR) is positioned for an artificial intelligence-driven inflection as rising ch
Can AEHR Turn AI Processor Tests Into Long-Term Revenue Streams?
Aehr's AI testing business gains momentum with major orders, new customer opportunities and a path toward recurring revenues.
Are Computer and Technology Stocks Lagging Aehr Test Systems (AEHR) This Year?
Here is how Aehr Test Systems (AEHR) and Fortinet (FTNT) have performed compared to their sector so far this year.
Butterfly Network Stock Is Just One Of 3 AI Small Cap Stocks
Strong US jobs data and firm wage growth keep the focus on interest rates and the cost of capital. While large companies debate how fast to invest, smaller AI focused stocks can often move quicker and test new ideas in automation, data and machine learning. This article highlights three early stage AI small caps from our US screener that could help you think differently about long term growth. The stocks covered below are just a sample, and the full screen surfaced 26 more AI small caps with...
Aehr Test Systems (AEHR) Climbs 13%; Hedge Fund Holdings Rocket by Eightfold
Aehr Test Systems (NASDAQ:AEHR) saw its share price climb by 13.10 percent on Friday as investors began positioning their portfolios ahead of business updates next week. According to the company, Chief Executive Officer Gayn Erickson and Chief Finance Officer Chris Siu are set to participate in meetings with institutional investors at the Lake Street Capital […]
William Blair Says These Stocks Are Must-Own Picks
William Blair Names 8 New Stock Picks: AI, Defense and Healthcare Stand Out
Explore More Analysis for AEHR
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.
Earnings snapshot
Next report Nov 2, 2026 (after the close, usually)
Frequently Asked Questions
Common investor questions about Aehr Test Systems, Inc.
Aehr Test Systems, Inc. (AEHR) is currently trading at $87.21. The RSI (14-day) is at 37.9, indicating neutral territory. Wall Street analysts have a consensus "none" recommendation. The mean analyst price target of $128.00 implies 46.8% upside from current levels. Volatility is high at 66.6% annualized, meaning significant price swings are common. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for Aehr Test Systems, Inc. (AEHR): The trailing P/E ratio is not available (the company may not be profitable). The forward P/E is 57.30. Price-to-Book is 12.34. Price-to-Sales is 54.39. Valuation should be compared to Semiconductor Equipment & Materials industry peers for context, as different sectors trade at different multiples.
Based on 5 analysts covering AEHR, the consensus price target is $128.00. This represents a 46.8% upside from the current price of $87.21. The range spans from a low target of $110.00 to a high target of $175.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "none". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Aehr Test Systems, Inc. (AEHR) does not currently pay a regular dividend. The company may be reinvesting profits into growth initiatives, or may not yet be profitable enough to distribute earnings to shareholders.
Key risks for Aehr Test Systems, Inc. (AEHR) investors include: 1. High volatility (66.6% annualized)—the stock can experience significant daily price swings. 2. The company is not currently profitable on a trailing basis, which creates earnings uncertainty. 3. Elevated short interest (16.5% of float) suggests significant bearish sentiment. 4. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 5. Semiconductor Equipment & Materials sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is Aehr Test Systems, Inc.'s (AEHR) current debt and financial health profile: Total debt stands at $9.88M. The debt-to-equity ratio is 0.05x, which is conservative and indicates a strong balance sheet with low leverage. The current ratio is 10.33, indicating strong short-term liquidity. The quick ratio is 7.60. The company holds $116.36M in cash and equivalents. Free cash flow is negative at -$1.96M, which could limit the company's ability to manage debt obligations.